Investment

Health

The healthcare sector offers huge potential to create societal impact. It is supported by a relentless demographic megatrend, with good opportunities fuelled by the AI and tech revolution.

We support investors by bringing together decades of expertise in advising on investment strategy and manager selection with powerful scientific and industry insights from the experts in our health analytics team. This unique combination allows us to identify the drivers behind change and therefore the best investment opportunities.

A world in flux: shaping a more positive future

Vista: LCP's investment magazine

Our latest edition explores insights into navigating today's volatile markets amidst geopolitical tensions and climate challenges. It uncovers demographic shifts, the urgency of climate action and opportunities in emerging markets.

Read now
Turning turbulence into tailwinds

Investment conference

2024 is the election year with over 60 countries going to the polls. As well as being a barometer for democracy, we may see geopolitics reshape global trade and economies, creating new risks and opportunities. At our conference we'll explore how agile investors can best position portfolios.

Join us
Investment Uncut: LCP's podcast about investing

Our hosts are joined by guests each week as they get beyond the jargon to try and bring sense to the world of investing and bring clarity to your investment decisions.

Listen & subscribe

Investing in healthcare can not only increase potential returns but also helps diversify investments and contribute to society by supporting a crucial area

Expert advice on investing in healthcare

We provide expert advice on all aspects of investing in healthcare by combining our investment and health capabilities into a single integrated service, helping investors to access the vast opportunities in this space.

The area of biotech and life sciences in particular has historically been a difficult area for investors, due to its high risk nature and the length of time needed to generate revenues. We can de-risk this exciting area to give investors greater confidence and increase their chances of delivering strong returns.

Our insights are generated from:

A market leading approach to using genomics to estimate drug success and repurposing opportunities at early development stages.
Experience in market access and evidence generation strategies to identify investments with strong prospects, as well as support companies already within the portfolio to help maximise value.
Medical, scientific and demographic experts providing economic modelling of population health trends to identify key areas of unmet need and therefore healthcare sectors with the most growth potential.

By taking our healthcare insights and combining them with our strategy overview, manager research and due diligence capabilities, we provide investors with a fully integrated end-to-end solution.